Flumedroxone: Difference between revisions
Rabin Bista (talk | contribs) No edit summary |
m Protected "Flumedroxone": Bot: Protecting all pages from category Drug ([Edit=Allow only administrators] (indefinite) [Move=Allow only administrators] (indefinite)) |
(No difference)
|
Latest revision as of 21:03, 18 August 2015
Clinical data | |
---|---|
Synonyms | (6S,10R,13S,17S)-17-acetyl-17-hydroxy-10,13-dimethyl-6-(trifluoromethyl)-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one 17-Acetyloxy-6α-(trifluoromethyl)preg-4-ene-3,20-dione |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C22H29F3O3 |
Molar mass | 398.459 g/mol |
3D model (JSmol) | |
| |
| |
(verify) |
WikiDoc Resources for Flumedroxone |
Articles |
---|
Most recent articles on Flumedroxone Most cited articles on Flumedroxone |
Media |
Powerpoint slides on Flumedroxone |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Flumedroxone at Clinical Trials.gov Clinical Trials on Flumedroxone at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Flumedroxone
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Flumedroxone Discussion groups on Flumedroxone Patient Handouts on Flumedroxone Directions to Hospitals Treating Flumedroxone Risk calculators and risk factors for Flumedroxone
|
Healthcare Provider Resources |
Causes & Risk Factors for Flumedroxone |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Flumedroxone is a corticosteroid derivative used to treat migraines. In one study, the benefit was largely limited to women with headache associated with premenstrual syndrome.[1]
References
- ↑ Bradley WG, Hudgson P, Foster JB, Newell DJ (August 1968). "Double-blind controlled trial of a micronized preparation of flumedroxone (Demigran) in prophylaxis of migraine". Br Med J. 3 (5617): 531–3. doi:10.1136/bmj.3.5617.531. PMC 1986487. PMID 4877801.